Latest Breaking News On - Note financing - Page 2 : comparemela.com

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCommonwealth of australiaNeil mareskyPsyence biomedPsyence biomedical ltd biomedCanadian securities exchangePsyence biomed divisionNewcourt acquisition corpPsyence groupPty ltdPsyence group incPurpose acquisition companyGroup incPsyence biomedical ltdBusiness combination

Psyence Group Inc Subsidiary Psyence Biomedical Ltd announces signing of definitive agreement for a convertible note in connection with planned business combination

TORONTO, Jan. 16, 2024 Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, today announced.

United statesUnited kingdomNeil mareskyPsyence biomedNewcourt acquisition companyPsyence biomedical ltd pubcoPsyence biomed divisionNewcourt acquisition corp nasdaqPsyence groupPsyence group incPurpose acquisition companyEllenoff grossman scholeCanadian securities exchangeGroup incPsyence biomedical ltdNote financing

Psyence Group Inc Subsidiary Psyence Biomedical Ltd

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) Psyence Group Inc (

United kingdomUnited statesPsyence biomedNeil mareskyPsyence group incCanadian securities exchangeEllenoff grossman scholePsyence biomedical ltd pubcoPsyence biomed divisionNewcourt acquisition corp nasdaqPsyence groupGroup incPsyence biomedical ltdNote financingNewcourt acquisition corpSecurities purchase agreement

FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION

VANCOUVER, BC, Dec. 19, 2023 /CNW/ - Filament Health Corp. , a clinical‐stage natural psychedelic drug development company, today announced that the Business Combination Agreement, by and.

British columbiaJupiter acquisition corporationBc ltdFilament healthFilament merger subFilament health corpBusiness combination agreementFirst amendmentProposed business combinationHelena global investment opportunitiesBusiness combinationNote financingCanada newswire

FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE

VANCOUVER, BC, Dec. 18, 2023 /CNW/ - Filament Health Corp. , a clinical‐stage natural psychedelic drug development company, today announced that the special meeting of its securityholders held.

United kingdomBritish columbiaUnited statesBenjamin lightburnJeremy weechDavida donohoe jrDonohoe advisory associatesFilament health corpHelena partners incCounsel for the listing qualifications departmentBc ltdExchange commissionJupiter acquisition corporationFilament healthBusiness corporations actSpecial meeting